vs
Ispire Technology Inc.（ISPR）与礼来（RNA）财务数据对比。点击上方公司名可切换其他公司
Ispire Technology Inc.的季度营收约是礼来的1.6倍（$20.3M vs $12.5M），Ispire Technology Inc.净利率更高（-32.5% vs -1398.3%，领先1365.8%），礼来同比增速更快（434.0% vs -51.5%），Ispire Technology Inc.自由现金流更多（$-4.0M vs $-156.9M），过去两年礼来的营收复合增速更高（138.5% vs -17.8%）
Ispire科技是一家专注于先进雾化硬件及配套耗材研发、生产与销售的全球化科技企业，主要服务尼古丁及合法大麻消费市场，下设硬件、品牌大麻产品两大核心业务板块，覆盖北美、欧洲、亚太等核心市场，为B端合作商及终端用户提供合规创新的雾化解决方案。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
ISPR vs RNA — 直观对比
营收规模更大
ISPR
是对方的1.6倍
$12.5M
营收增速更快
RNA
高出485.5%
-51.5%
净利率更高
ISPR
高出1365.8%
-1398.3%
自由现金流更多
ISPR
多$152.8M
$-156.9M
两年增速更快
RNA
近两年复合增速
-17.8%
损益表 — Q2 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.3M | $12.5M |
| 净利润 | $-6.6M | $-174.4M |
| 毛利率 | 17.1% | — |
| 营业利润率 | -33.9% | -1513.5% |
| 净利率 | -32.5% | -1398.3% |
| 营收同比 | -51.5% | 434.0% |
| 净利润同比 | 17.4% | -117.0% |
| 每股收益（稀释后） | $-0.12 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ISPRRNA
| Q4 25 | $20.3M | — | ||
| Q3 25 | $30.4M | $12.5M | ||
| Q2 25 | $20.1M | $3.8M | ||
| Q1 25 | $26.2M | $1.6M | ||
| Q4 24 | $41.8M | $3.0M | ||
| Q3 24 | $39.3M | $2.3M | ||
| Q2 24 | $37.3M | $2.0M | ||
| Q1 24 | $30.0M | $3.5M |
净利润ISPRRNA
| Q4 25 | $-6.6M | — | ||
| Q3 25 | $-3.3M | $-174.4M | ||
| Q2 25 | $-14.8M | $-157.3M | ||
| Q1 25 | $-10.9M | $-115.8M | ||
| Q4 24 | $-8.0M | $-102.3M | ||
| Q3 24 | $-5.6M | $-80.4M | ||
| Q2 24 | $-3.5M | $-70.8M | ||
| Q1 24 | $-5.9M | $-68.9M |
毛利率ISPRRNA
| Q4 25 | 17.1% | — | ||
| Q3 25 | 17.0% | — | ||
| Q2 25 | 12.3% | — | ||
| Q1 25 | 18.2% | — | ||
| Q4 24 | 18.5% | — | ||
| Q3 24 | 19.5% | — | ||
| Q2 24 | 28.3% | — | ||
| Q1 24 | 20.4% | — |
营业利润率ISPRRNA
| Q4 25 | -33.9% | — | ||
| Q3 25 | -8.9% | -1513.5% | ||
| Q2 25 | -72.7% | -4448.7% | ||
| Q1 25 | -40.4% | -8360.9% | ||
| Q4 24 | -17.6% | -4069.6% | ||
| Q3 24 | -13.4% | -4200.9% | ||
| Q2 24 | -9.2% | -4040.4% | ||
| Q1 24 | -18.8% | -2178.6% |
净利率ISPRRNA
| Q4 25 | -32.5% | — | ||
| Q3 25 | -10.7% | -1398.3% | ||
| Q2 25 | -73.4% | -4089.3% | ||
| Q1 25 | -41.5% | -7360.0% | ||
| Q4 24 | -19.1% | -3439.5% | ||
| Q3 24 | -14.2% | -3441.7% | ||
| Q2 24 | -9.4% | -3461.8% | ||
| Q1 24 | -19.7% | -1943.4% |
每股收益（稀释后）ISPRRNA
| Q4 25 | $-0.12 | — | ||
| Q3 25 | $-0.06 | $-1.27 | ||
| Q2 25 | $-0.26 | $-1.21 | ||
| Q1 25 | $-0.19 | $-0.90 | ||
| Q4 24 | $-0.14 | $-0.80 | ||
| Q3 24 | $-0.10 | $-0.65 | ||
| Q2 24 | $-0.07 | $-0.65 | ||
| Q1 24 | $-0.11 | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $17.6M | $350.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-7.7M | $1.9B |
| 总资产 | $84.4M | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ISPRRNA
| Q4 25 | $17.6M | — | ||
| Q3 25 | $22.7M | $350.2M | ||
| Q2 25 | $24.4M | $243.9M | ||
| Q1 25 | $23.5M | $254.2M | ||
| Q4 24 | $34.4M | $219.9M | ||
| Q3 24 | $37.7M | $370.2M | ||
| Q2 24 | $35.1M | $575.8M | ||
| Q1 24 | $39.5M | $471.4M |
股东权益ISPRRNA
| Q4 25 | $-7.7M | — | ||
| Q3 25 | $-1.8M | $1.9B | ||
| Q2 25 | $604.7K | $1.2B | ||
| Q1 25 | $14.8M | $1.3B | ||
| Q4 24 | $24.2M | $1.4B | ||
| Q3 24 | $30.7M | $1.5B | ||
| Q2 24 | $34.5M | $1.2B | ||
| Q1 24 | $35.9M | $830.9M |
总资产ISPRRNA
| Q4 25 | $84.4M | — | ||
| Q3 25 | $96.4M | $2.1B | ||
| Q2 25 | $102.2M | $1.4B | ||
| Q1 25 | $115.7M | $1.5B | ||
| Q4 24 | $132.0M | $1.6B | ||
| Q3 24 | $129.0M | $1.6B | ||
| Q2 24 | $122.6M | $1.3B | ||
| Q1 24 | $108.0M | $951.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.0M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | $-4.0M | $-156.9M |
| 自由现金流率自由现金流/营收 | -19.9% | -1257.6% |
| 资本支出强度资本支出/营收 | 0.3% | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-14.2M | $-592.3M |
8季度趋势，按日历期对齐
经营现金流ISPRRNA
| Q4 25 | $-4.0M | — | ||
| Q3 25 | $-1.2M | $-156.2M | ||
| Q2 25 | $4.7M | $-199.7M | ||
| Q1 25 | $-12.5M | $-124.8M | ||
| Q4 24 | $-3.2M | $-99.9M | ||
| Q3 24 | $3.6M | $-65.6M | ||
| Q2 24 | $-1.4M | $-65.0M | ||
| Q1 24 | $3.4M | $-70.4M |
自由现金流ISPRRNA
| Q4 25 | $-4.0M | — | ||
| Q3 25 | $-1.2M | $-156.9M | ||
| Q2 25 | $3.7M | $-203.0M | ||
| Q1 25 | $-12.7M | $-128.6M | ||
| Q4 24 | $-3.2M | $-103.8M | ||
| Q3 24 | $3.3M | $-67.3M | ||
| Q2 24 | $-2.2M | $-65.5M | ||
| Q1 24 | $3.3M | $-71.3M |
自由现金流率ISPRRNA
| Q4 25 | -19.9% | — | ||
| Q3 25 | -3.9% | -1257.6% | ||
| Q2 25 | 18.6% | -5277.1% | ||
| Q1 25 | -48.4% | -8174.3% | ||
| Q4 24 | -7.7% | -3491.0% | ||
| Q3 24 | 8.5% | -2881.8% | ||
| Q2 24 | -5.9% | -3204.6% | ||
| Q1 24 | 10.9% | -2012.3% |
资本支出强度ISPRRNA
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.0% | 5.7% | ||
| Q2 25 | 4.8% | 86.9% | ||
| Q1 25 | 0.7% | 238.6% | ||
| Q4 24 | 0.1% | 131.7% | ||
| Q3 24 | 0.7% | 72.9% | ||
| Q2 24 | 2.0% | 26.0% | ||
| Q1 24 | 0.3% | 25.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
